Schmitt S, Döllinger C, Maier A, Herpel E, Schirmacher P, Kirsten R
Institut für Pathologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Deutschland.
Pathologe. 2018 Jul;39(4):320-327. doi: 10.1007/s00292-018-0444-8.
Founded in 1386, Heidelberg University is Germany's oldest and one of Europe's most reputable universities. As a scientific hub in Germany, Heidelberg is home to several internationally renowned medical research facilities that have an enormous demand for biomaterial samples and data-especially in the field of translational and cancer research.The main objective of the BMBF-funded project "BioMaterialBank Heidelberg" (BMBH) was the harmonization of local biobanking under the same administrative roof through the implementation of common and standardized project, data, and quality management procedures.In the very beginning, existing structures and processes of the participating biobanks in Heidelberg were identified and a common administrative structure with central representatives for IT and quality management (QM) was established to coordinate all BMBH activities.Over time, implementation of consented structures and processes took place, also revealing organizational challenges that had to be solved concerning, for example, differences in sample handling and the definition of consistent access regulations.We will discuss below these challenges as well as the opportunities of building a centralized biobank and show how issues can be resolved using the example of the BMBH.
海德堡大学成立于1386年,是德国最古老且欧洲最负盛名的大学之一。作为德国的一个科学中心,海德堡拥有多个国际知名的医学研究机构,这些机构对生物材料样本和数据有巨大需求,尤其是在转化医学和癌症研究领域。由德国联邦教育及研究部(BMBF)资助的“海德堡生物材料库”(BMBH)项目的主要目标是,通过实施通用且标准化的项目、数据及质量管理程序,在同一管理框架下整合当地的生物样本库。一开始,对海德堡参与项目的生物样本库的现有结构和流程进行了梳理,并建立了一个共同的管理架构,设有信息技术和质量管理(QM)的中央代表,以协调BMBH的所有活动。随着时间的推移,已同意的结构和流程得以实施,同时也暴露出一些组织方面的挑战,例如样本处理的差异以及统一访问规定的定义等问题都需要解决。我们将在下文讨论这些挑战以及建立集中式生物样本库的机遇,并以BMBH为例说明如何解决这些问题。